Andere Sprachen 908 Devices Inc.

Aktien

A2QK1S

US65443P1021

MASS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 03.05.2024			% 5 Tage	% 1. Jan.
5,65 ^USD	-0,35 %		-0,35 %	-49,64 %

30.04.	Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024
30.04.	908 Devices Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M	30.04.
908 Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook	30.04.
908 Devices Inc. Provides Revenue Guidance for the Full Year 2024	30.04.
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering	30.04.
908 Devices Inc. acquired CAM2 Technologies, LLC for $76.6 million.	30.04.
Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.	29.04.
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024	23.04.
La technologie d'identification chimique des traces de 908 Devices est adoptée par les agences européennes	12.03.
908 Devices Trace Chemical Identification Technology Adopted by European Agencies	12.03.
908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies	12.03.
908 Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05.03.
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05.03.
Earnings Flash (MASS) 908 DEVICES Reports Q4 Revenue $14.4M	05.03.
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook	05.03.
908 Devices Inc. Provides Earnings Guidance for the Full Year 2024	05.03.
North American Morning Briefing : S&P 500 Futures -2-	05.03.
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform	01.03.
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform	29.02.
908 Devices to Participate in Upcoming Investor Conferences	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen 908 Devices Inc.

Aktien

A2QK1S

US65443P1021

MASS

Andere Sprachen

Filter